20-417634-G-T

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_031229.4(RBCK1):​c.261+15G>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.16 in 1,611,074 control chromosomes in the GnomAD database, including 22,139 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 1842 hom., cov: 32)
Exomes 𝑓: 0.16 ( 20297 hom. )

Consequence

RBCK1
NM_031229.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.385
Variant links:
Genes affected
RBCK1 (HGNC:15864): (RANBP2-type and C3HC4-type zinc finger containing 1) Enables several functions, including identical protein binding activity; protein sequestering activity; and ubiquitin binding activity. Involved in several processes, including T cell receptor signaling pathway; cellular protein metabolic process; and regulation of DNA-binding transcription factor activity. Part of LUBAC complex. Implicated in glycogen storage disease. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BP6
Variant 20-417634-G-T is Benign according to our data. Variant chr20-417634-G-T is described in ClinVar as [Benign]. Clinvar id is 403367.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr20-417634-G-T is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.17 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
RBCK1NM_031229.4 linkuse as main transcriptc.261+15G>T intron_variant ENST00000356286.10 NP_112506.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
RBCK1ENST00000356286.10 linkuse as main transcriptc.261+15G>T intron_variant 1 NM_031229.4 ENSP00000348632.6 Q9BYM8-1

Frequencies

GnomAD3 genomes
AF:
0.146
AC:
22230
AN:
152028
Hom.:
1845
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.109
Gnomad AMI
AF:
0.256
Gnomad AMR
AF:
0.146
Gnomad ASJ
AF:
0.260
Gnomad EAS
AF:
0.00212
Gnomad SAS
AF:
0.102
Gnomad FIN
AF:
0.156
Gnomad MID
AF:
0.278
Gnomad NFE
AF:
0.173
Gnomad OTH
AF:
0.175
GnomAD3 exomes
AF:
0.144
AC:
36062
AN:
250354
Hom.:
3060
AF XY:
0.145
AC XY:
19690
AN XY:
135354
show subpopulations
Gnomad AFR exome
AF:
0.104
Gnomad AMR exome
AF:
0.126
Gnomad ASJ exome
AF:
0.264
Gnomad EAS exome
AF:
0.000762
Gnomad SAS exome
AF:
0.104
Gnomad FIN exome
AF:
0.149
Gnomad NFE exome
AF:
0.176
Gnomad OTH exome
AF:
0.176
GnomAD4 exome
AF:
0.161
AC:
235085
AN:
1458928
Hom.:
20297
Cov.:
33
AF XY:
0.161
AC XY:
116470
AN XY:
725168
show subpopulations
Gnomad4 AFR exome
AF:
0.106
Gnomad4 AMR exome
AF:
0.127
Gnomad4 ASJ exome
AF:
0.266
Gnomad4 EAS exome
AF:
0.000581
Gnomad4 SAS exome
AF:
0.104
Gnomad4 FIN exome
AF:
0.148
Gnomad4 NFE exome
AF:
0.172
Gnomad4 OTH exome
AF:
0.166
GnomAD4 genome
AF:
0.146
AC:
22237
AN:
152146
Hom.:
1842
Cov.:
32
AF XY:
0.145
AC XY:
10768
AN XY:
74374
show subpopulations
Gnomad4 AFR
AF:
0.109
Gnomad4 AMR
AF:
0.146
Gnomad4 ASJ
AF:
0.260
Gnomad4 EAS
AF:
0.00212
Gnomad4 SAS
AF:
0.103
Gnomad4 FIN
AF:
0.156
Gnomad4 NFE
AF:
0.173
Gnomad4 OTH
AF:
0.172
Alfa
AF:
0.171
Hom.:
3336
Bravo
AF:
0.146
Asia WGS
AF:
0.0550
AC:
194
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:2
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMar 29, 2016Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -
Benign, criteria provided, single submitterclinical testingUnidad de Genómica Garrahan, Hospital de Pediatría GarrahanNov 12, 2023This variant is classified as Benign based on local population frequency. This variant was detected in 26% of patients studied by a panel of primary immunodeficiencies. Number of patients: 25. Only high quality variants are reported. -
not provided Benign:2
Benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
Benign, criteria provided, single submitterclinical testingGeneDxMay 14, 2021- -
Polyglucosan body myopathy type 1 Benign:1
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpFeb 01, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
7.0
DANN
Benign
0.76
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs11698154; hg19: chr20-398278; API